Chinese Journal of Tissue Engineering Research ›› 2013, Vol. 17 ›› Issue (6): 1116-1121.doi: 10.3969/j.issn.2095-4344.2013.06.028

Previous Articles     Next Articles

In vitro induced differentiation of placenta-derived mesenchymal stem cells

Li Li-chun1, He Zhi2, Li Jian-ping1   

  1. 1 Liaoning Blood Center, Shenyang 110044, Liaoning Province, China
    2 Fourth People’s Hospital of Shenyang, Shenyang 110044, Liaoning Province, China
  • Received:2012-04-13 Revised:2012-06-18 Online:2013-02-05 Published:2013-02-05
  • Contact: Li Jian-ping, Chief physician, Liaoning Blood Center, Shenyang 110044, Liaoning Province, China ljp_63@yahoo.com
  • About author:Li Li-chun★, Master, Physician, Liaoning Blood Center, Shenyang 110044, Liaoning Province, China lichunli2009@yahoo.cn

Abstract:

BACKGROUND: Compared to bone marrow-, peripheral blood-, fat- and embryo-derived mesenchymal stem cells, umbilical cord- and placenta-derived mesenchymal stem cells possess advantages including wide source, ease of harvesting, no immunological rejection or ethical compromise.
OBJECTIVE: To investigate the methods to in vitro isolate, culture and sub-culture of placenta-derived mesenchymal stem cells, providing experimental basis for clinical application of placenta-derived mesenchymal stem cells.
METHODS: A computer-based online retrieval was performed to search papers regarding placenta-derived mesenchymal stem cells published in PubMed database, Chinese Journal Full Text Database, Wanfang database using key words “placenta-derived mesenchymal stem cells, induction and differentiation in vitro”. A total of 98 papers were retrieved, and 33 were suitable for final analysis.
RESULTS AND CONCLUSION: Placenta-derived mesenchymal stem cells are in the stage of basic research in China, but some progress has been made in basic research and clinical application of placenta-derived mesenchymal stem cells in countries outside China. Placenta-derived mesenchymal stem cells possess advantages including wide source, ease in sample harvesting and no immunological rejection or ethical compromise as well as less pain, fewer infection opportunities and stronger proliferative capacity compared to bone marrow donation or peripheral blood collection. For these reasons, placenta-derived mesenchymal stem cells should be further studied.

Key words: stem cells, stem cell review, placenta-derived mesenchymal stem cells, biological characteristics, induced differentiation, isolation and culture, primary, passage, multi-direction differentiation, differentiation potential, placenta, clinical application, review literature, other grants-supported paper

CLC Number: